UNSPSC 51283102: Caspofungin

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F0XDI6ZL63. European Medicines Agency schedules Caspofungin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16405MIG. Caspofungin generally arises in the molecular formula C52H88N10O15. The term CASPOFUNGIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 no. 3, 1999, list 42.) Most nations schedule caspofungin under HS 29419000 and SITC 54139.

As of Q4 2014, CASPOFUNGIN remains the US FDA Preferred Term for this commodity. Caspofungin bears US NLM identifiers UMLS ID C0537894 and NCI Concept Code C28910. SMILES: OC1C2N(CC1)C(=O)C(NC(=O)C(NC(=O)C1N(CC(O)C1)C(=O)C(NC(=O)C(NC(=O)CCCCCCCCC(CC(CC)C)C)CC(O)C(NC2=O)NCCN)C(O)C)C(O)C(O)C1CCC(O)CC1)C(O)CCN.

UNSPSC 51283102 Caspofungin (Commodity) represents pharmaceutical products procured by state and local health agencies, though recent activity shows limited direct solicitation under this specific code. State and local governments use this Commodity code to purchase antifungal medications and related pharmaceutical inventory through cooperative purchasing agreements and competitive bidding processes. The issuing bodies soliciting pharmaceutical products at this tier include state departments of public health and county health authorities, who typically source medications through piggyback contracts leveraging established vendor relationships and consortia agreements to streamline procurement and control costs.

Recent opportunities tagged under this code show activity concentrated in the Southeast and Midwest. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) via the MMCAP Infuse consortium for a 12-month initial term with two renewal options, though the contract supplied Doxycycline Hyclate and Ciprofloxacin Hydrochloride rather than caspofungin. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, response due July 26, 2023. The source shows no active open solicitations specifically for caspofungin; recent pharmaceutical procurements under related codes favor consortium vehicles and fixed-fee arrangements with established vendors, and vendors pursuing this code should monitor state health department announcements for piggyback opportunities and cooperative purchasing vehicles.